|
|
Volumn 117, Issue , 1998, Pages 511-524
|
|
Prospectives for cell and gene therapy in Huntington's disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BRAIN DERIVED NEUROTROPHIC FACTOR;
CILIARY NEUROTROPHIC FACTOR;
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;
NERVE GROWTH FACTOR;
NEUROTROPHIN;
NEUROTROPHIN 3;
TRANSFORMING GROWTH FACTOR BETA;
VIRUS VECTOR;
ADENOVIRUS;
ANIMAL MODEL;
CLINICAL TRIAL;
CONFERENCE PAPER;
GENE THERAPY;
GENE TRANSFER;
HERPES SIMPLEX VIRUS;
HUMAN;
HUNTINGTON CHOREA;
INTRATHECAL DRUG ADMINISTRATION;
NERVE GRAFT;
NEUROLOGIC DISEASE;
NONHUMAN;
PARKINSON DISEASE;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
|
|
EID: 0031770917
PISSN: 00796123
EISSN: None
Source Type: Book Series
DOI: 10.1016/s0079-6123(08)64036-4 Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (117)
|
